Local News: Atlanta, GA 

 | 

Sign Up

 | 

Sign In

Sequenom News Editors

News Widget

Display the Sequenom news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Sequenom News

News on Sequenom (Ticker: SQNM) continually updated from thousands of sources around the net.

Friday | BioSpace

Stephen Zaniboni Joins TrovaGene, Inc. as Chief Financial Officer

Mr. Zaniboni previously served as Chief Financial Officer of healthcare software solutions company Awarepoint and XIFIN Inc., a provider of revenue cycle management for diagnostic service providers.

Comment?

Related Topix: Awarepoint, Oncology, Medicine, Biotech, Healthcare Industry, Leukemia

Tue Feb 07, 2012

Medical News Today

Non-Invasive DNA Test That Identifies Down Syndrome In Pregnancy...

Main Category: Pregnancy / Obstetrics Also Included In: Pediatrics / Children's Health ; Genetics Article Date: 07 Feb 2012 - 0:00 PST A newly available DNA-based prenatal blood test that can identify a pregnancy with Down syndrome can also identify two additional chromosome abnormalities: trisomy 18 and trisomy 13 .The test for all three defects ... (more)

Comment?

Related Topix: Genetics, Medicine, Biology, Science, Obstetrics and Gynecology, Pediatrics, Biotech, Healthcare Industry, Sequenom

Mon Feb 06, 2012

AmericanBankingNews.com

Sequenom (SQNM) Upgraded by Zacks Investment Research to "Outperform"

Sequenom was upgraded by Zacks Investment Research from a "neutral" rating to an "outperform" rating in a research note issued to investors on Monday.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Genetics

Sun Feb 05, 2012

Go Local

Health | Women & Infants Researchers Discover New Test for Birth Defects

A newly available DNA-based prenatal blood test that can identify a pregnancy with Down syndrome can also identify two additional chromosome abnormalities: trisomy 18 and trisomy 13 .

Comment?

Related Topix: Genetics, Medicine, Biology, Science, Biotech, Healthcare Industry, Brown University, Sequenom

Thu Feb 02, 2012

EurekAlert!

DNA test that identifies Down syndrome in pregnancy can also detect trisomy 18 and trisomy 13

A newly available DNA-based prenatal blood test that can identify a pregnancy with Down syndrome can also identify two additional chromosome abnormalities: trisomy 18 and trisomy 13 .

Comment?

Related Topix: Genetics, Medicine, Biology, Science, Biotech, Healthcare Industry, Sequenom

Mon Jan 30, 2012

AmericanBankingNews.com

Sequenom (SQNM) Shares Given a "Buy" Rating by Auriga Analysts

Separately, analysts at Dougherty & Co initiated coverage on shares of Sequenom in a research note to investors on Thursday, January 5th.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Genetics

Wed Jan 25, 2012

Freshnews

Sequenom Announces Exercise in Full of Over-Allotment Option and...

Sequenom, Inc. today announced the completion of an underwritten public offering of 14,950,000 shares of its common stock, including 1,950,000 shares sold pursuant to the full exercise of an over-allotment option previously granted to the underwriters.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Investment Banking, Financial Services, Jefferies Group, Investment Services, Securities and Exchange Commission, Corporate / Securities Law, Law, Attention

Fri Jan 20, 2012

Freshnews

Sequenom Announces Proposed Public Offering of Common Stock

Sequenom, Inc. today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Securities and Exchange Commission, Corporate / Securities Law, Law, Attention

San Diego Source

Sequenom expects to raise $54M from stock sale

Diagnostic test maker Sequenom Inc . said Friday it will sell 13 million shares of its stock for $4.15 each.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

CBS News

Sequenom expects to raise $54M from stock sale

SAN DIEGO &#8212 Diagnostic test maker Sequenom Inc. said Friday it will sell 13 million shares of its stock for $4.15 each.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Sequenom

Atlanta Jobs

Also on Topix